Ondansetron
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00904 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 24 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | Tourette syndrome | KG + DL |
| 3 | trichotillomania | KG + DL |
| 4 | schizotypal personality disorder | KG + DL |
| 5 | schizoid personality disorder | KG + DL |
| 6 | paranoid personality disorder | KG + DL |
| 7 | histrionic personality disorder (disease) | KG + DL |
| 8 | common cold | KG + DL |
| 9 | allergic urticaria | KG + DL |
| 10 | acute intermittent porphyria | KG + DL |
| 11 | obsessive-compulsive disorder | KG + DL |
| 12 | myofascial pain syndrome | KG + DL |
| 13 | cold urticaria | KG + DL |
| 14 | angioedema | KG + DL |
| 15 | headache disorder | KG + DL |
| 16 | idiopathic granulomatous myositis | KG + DL |
| 17 | myositis fibrosa | KG + DL |
| 18 | Plasmodium falciparum malaria | KG + DL |
| 19 | manic bipolar affective disorder | KG + DL |
| 20 | tendinitis | KG + DL |
| 21 | trigeminal autonomic cephalalgia | KG + DL |
| 22 | fibromyalgia | KG + DL |
| 23 | psychotic disorder | KG + DL |
| 24 | inclusion body myositis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.